Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Antibodies Inc Ad CMV hTSHR 289 Adenovirus, 1 to 1.3 x 10^12 particles/mL, A195 buffer, -80 °C, 50 μL minimum aliquot, Screw cap tube
SDP

Supplier:  Antibodies Inc 91VQ013

Encompass

The Ad CMV hTSHR 289 Adenovirus is a replication-deficient viral vector designed for robust gene expression in research applications. It utilizes a CMV promoter for consistent expression of the hTSHR gene, built on an Ad5 E1/E3 deleted backbone for enhanced safety. This product is meticulously purified to ensure high stability and performance across experiments. It is specifically intended for studies focused on thyroid cell metabolism and hyperthyroidism-related pathways.

  • Product type: Adenovirus
  • Target gene: hTSHR (human Thyroid Stimulating Hormone Receptor)
  • Promoter: CMV
  • Viral backbone: Ad5 E1/E3 deleted
  • Titer: 1 to 1.3 x 10^12 particles/mL
  • Purification method: CsCl gradients (2 rounds)
  • Formulation buffer: A195 buffer
  • Storage temperature: -80 °C
  • Minimum aliquot volume: 50 μL
  • Storage container: Screw cap tube
  • Intended use: Research use only

Catalog No. NC3729910


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.